Investigation of Euphorbia Lathyris L. Seed's Mechanisms in Colorectal Cancer Treatment Through Network Pharmacology and Molecular Docking Approaches - Takeaways - MDSpire

Investigation of Euphorbia Lathyris L. Seed's Mechanisms in Colorectal Cancer Treatment Through Network Pharmacology and Molecular Docking Approaches

  • By

  • Xiaohong Gao

  • Hongjuan Zhang

  • Yilin Wang

  • Peizhen Hu

  • March 11, 2026

  • 0 min

Share

  • 1

    Colorectal cancer (CRC) is a leading cause of cancer-related deaths, necessitating the development of novel therapeutic strategies.

  • 2

    Current CRC treatments have significant limitations, including toxicity, drug resistance, and applicability to specific patient populations.

  • 3

    Traditional Chinese Medicine (TCM) shows promise in CRC treatment through multi-component and multi-target mechanisms.

  • 4

    Euphorbia Lathyris L. Seed is identified as a TCM with potential anti-cancer properties, including apoptosis and cytotoxic activities.

  • 5

    Network pharmacology is employed to explore the bioactive compounds and mechanisms of Euphorbia Lathyris L. Seed in CRC treatment.

Original Source(s)

Investigation of Euphorbia Lathyris L. Seed's Mechanisms in Colorectal Cancer Treatment Through Network Pharmacology and Molecular Docking Approaches

  • by Xiaohong Gao, Hongjuan Zhang, Yilin Wang, Peizhen Hu

  • March 11, 2026

Related Content

Bridging aging and colorectal cancer: Synergistic roles of inflammaging and immunosenescence

SAGES colorectal and metabolic bariatric surgery committee joint task force call to action for synchronized severe obesity and colorectal cancer management

Baicalin suppresses colorectal cancer proliferation and induces M1 polarization of tumor-associated macrophages by promoting proteasomal degradation of HK2